FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice.
FGFR
cholangiocarcinoma
erdafitinib
hyperphosphatemia
pemigatinib
urothelial carcinoma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
13 Jun 2021
13 Jun 2021
Historique:
received:
04
05
2021
revised:
07
06
2021
accepted:
08
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Fibroblast Growth Factor receptor (FGFR) pathway aberrations have been implicated in approximately 7% of the malignancies. As our knowledge of FGFR aberrations in cancer continues to evolve, FGFR inhibitors emerged as potential targeted therapeutic agents. The promising results of pemigatinib and infigratinib in advanced unresectable cholangiocarcinoma harboring
Identifiants
pubmed: 34199304
pii: cancers13122968
doi: 10.3390/cancers13122968
pmc: PMC8231807
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Cancer Discov. 2013 Mar;3(3):264-79
pubmed: 23418312
Cancer Immunol Res. 2019 Sep;7(9):1457-1471
pubmed: 31331945
Front Endocrinol (Lausanne). 2020 May 08;11:293
pubmed: 32457699
Nat Rev Dis Primers. 2017 Jul 13;3:17044
pubmed: 28703220
Clin Cancer Res. 2015 Jun 15;21(12):2684-94
pubmed: 26078430
Aliment Pharmacol Ther. 2016 Apr;43(8):884-898
pubmed: 26913381
J Ren Nutr. 2021 Jan;31(1):21-34
pubmed: 32386937
Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4):
pubmed: 31371345
Cancer Discov. 2018 Jul;8(7):812-821
pubmed: 29848605
Ann Oncol. 2017 Jun 1;28(6):1316-1324
pubmed: 29177434
J Ren Nutr. 2019 Mar;29(2):156-162
pubmed: 30087012
Trends Genet. 2004 Nov;20(11):563-9
pubmed: 15475116
EMBO J. 2021 Jun 4;:e107182
pubmed: 34086370
PLoS One. 2015 Dec 04;10(12):e0144119
pubmed: 26636968
Mol Cancer Ther. 2020 Mar;19(3):847-857
pubmed: 31911531
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13379-84
pubmed: 25139991
Inflamm Allergy Drug Targets. 2012 Feb;11(1):3-14
pubmed: 22309079
J Cancer. 2020 Feb 3;11(8):2000-2007
pubmed: 32127928
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21737-42
pubmed: 21098263
Kidney Int. 2014 Sep;86(3):638-47
pubmed: 24646861
J Clin Oncol. 2018 Jan 20;36(3):276-282
pubmed: 29182496
J Endocrinol. 2007 Jul;194(1):1-10
pubmed: 17592015
Front Endocrinol (Lausanne). 2016 Jan 19;6:193
pubmed: 26834701
Am J Kidney Dis. 2018 Jul;72(1):155-156
pubmed: 29655498
Clin J Am Soc Nephrol. 2011 Feb;6(2):257-64
pubmed: 21183586
Chem Biol. 2010 Mar 26;17(3):285-95
pubmed: 20338520
N Engl J Med. 2019 Jul 25;381(4):338-348
pubmed: 31340094
Front Oncol. 2019 Mar 26;9:179
pubmed: 30972293
Lancet Oncol. 2020 May;21(5):671-684
pubmed: 32203698
Hepatology. 2009 Jan;49(1):297-305
pubmed: 19085950
Oncogene. 2013 Jun 20;32(25):3059-70
pubmed: 22869148
Bone Res. 2014 Apr 29;2:14003
pubmed: 26273516
Cancer Discov. 2021 Feb;11(2):326-339
pubmed: 33218975
PLoS One. 2011 Mar 18;6(3):e17868
pubmed: 21437243
JAMA Dermatol. 2017 Jul 1;153(7):723-725
pubmed: 28538953
Cancer Treat Rev. 2019 Aug;78:1-7
pubmed: 31255945
Drugs. 2020 Jun;80(9):923-929
pubmed: 32472305
Ann Oncol. 2014 Mar;25(3):552-563
pubmed: 24265351
Drugs. 2019 Jun;79(9):1017-1021
pubmed: 31161538
Cancer Discov. 2017 Mar;7(3):252-263
pubmed: 28034880
Dermatol Pract Concept. 2020 Jun 29;10(3):e2020074
pubmed: 32642317
Br J Cancer. 2019 Jan;120(2):165-171
pubmed: 30420614
J Natl Compr Canc Netw. 2008 Jan;6 Suppl 1:S1-21; quiz S22-4
pubmed: 18289497
Curr Cancer Drug Targets. 2009 Aug;9(5):639-51
pubmed: 19508171
Cold Spring Harb Perspect Biol. 2013 Jun 01;5(6):
pubmed: 23732477
Mol Cancer Res. 2009 Jan;7(1):41-54
pubmed: 19147536
Genes Cells. 2016 Oct;21(10):1049-1058
pubmed: 27558949
Cancer Discov. 2019 Aug;9(8):1064-1079
pubmed: 31109923
Cancer Immunol Res. 2016 Jul;4(7):563-8
pubmed: 27197067
Adv Cancer Res. 1993;60:1-41
pubmed: 8417497
J Clin Oncol. 2014 Jun 10;32(17):1840-50
pubmed: 24733803
Int J Mol Med. 2016 Jul;38(1):3-15
pubmed: 27245147
Nat Rev Cancer. 2010 Feb;10(2):116-29
pubmed: 20094046
Oncologist. 2021 Feb;26(2):e316-e326
pubmed: 33021006
Cells. 2021 May 14;10(5):
pubmed: 34068954
Drug Discov Today. 2011 Dec;16(23-24):1052-60
pubmed: 21875682
Clin Cancer Res. 2016 Jan 1;22(1):259-67
pubmed: 26373574
Cell Physiol Biochem. 2014;33(3):633-45
pubmed: 24642893
Clin Cancer Res. 2011 Oct 1;17(19):6130-9
pubmed: 21953501
J Cutan Pathol. 2018 Oct;45(10):786-790
pubmed: 30021048
Nat Cell Biol. 2015 Sep;17(9):1193-204
pubmed: 26302407
Cancer Res. 1998 Jan 15;58(2):352-61
pubmed: 9443417
Br J Cancer. 2015 Mar 3;112(5):841-50
pubmed: 25688743
Clin Cancer Res. 2020 Feb 15;26(4):764-774
pubmed: 31585937
Breast Cancer Res. 2015 Nov 18;17:141
pubmed: 26581390